Enes Erul

22PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyPredictive and prognostic markersCancer geneticsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 26, 2026
Upfront Versus Deferred CDK4/6 Inhibitor Use in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Study.

|Jun 24, 2026
Epidemiology and Clinical Profiles of Bacteroides fragilis Bacteremia in a Tertiary Care Setting: A 5-Year Review.

|May 04, 2026
Serum Carcinoembryonic Antigen Levels Across Molecular Subtypes and Their Clinical and Prognostic Implications in Metastatic Non-Small Cell Lung Cancer.

|Feb 25, 2026
Imposter Syndrome, Burnout, and Maladaptive Perfectionism Among Oncology Professionals: A Global Cross-Sectional Study.

Enes Erul, Vilma Pacheco-Barcia, Ali Alkan

|Jan 28, 2026
Old Drug, New Science: Metformin and the Future of Pharmaceutics.

Alfredo Caturano, Davide Nilo, Roberto Nilo

|Nov 27, 2025
Assessing the Influence of Proton Pump Inhibitors on Clinical Outcomes in Hormone Receptor-Positive Metastatic Breast Cancer Patients Receiving CDK4/6 Inhibitors: Evidence from a Ribociclib-Dominant Cohort.

Enes Erul, Nejat Emre Öksüz, Erman Akkus

Pageof 4

Frequent Collaborators

7 joint publications

Taha Koray Sahin

5 joint publications

Deniz Can Guven

4 joint publications

Meliha Cagla Sonmezer

3 joint publications

Murat Akova